Benlysta SC Now Approved for Lupus Nephritis Under Ontario Drug Benefit Program

How to Access Benlysta SC for Lupus Nephritis in Ontario

Benlysta SC Now Available Under Ontario Drug Benefit

Effective Date: February 28, 2025

Discover how the inclusion of Benlysta SC in the Ontario Drug Benefit Program marks a significant advancement for lupus nephritis patients, ensuring broader access to essential treatment options.

Reimbursement & Access

The reimbursement criteria for Benlysta SC will be listed in the Frequently Requested Drugs section on the Ministry of Health’s website:

A Summary of Listing Changes (Edition No. 43 – March 2025) has been published by the Ministry and is available for download:

Ontario Drug Benefit (ODB) Formulary

The Formulary, Summaries of Changes, and Bulletins are available in a searchable electronic version (e-Formulary), which will be updated on March 31, 2025.

Lupus Canada appreciates the efforts being made to improve treatment access for lupus nephritis patients and will continue to advocate for expanded healthcare coverage.

Lupus Blog Articles:

Anifrolumab Now Covered Under BC PharmaCare for Lupus Treatment

Read

Belimumab for Lupus Nephritis in BC Now Approved Under BC Renal Formulary

Read

A Mother’s Lupus Story: Carolina and Luca’s Journey

Read